본문 바로가기

Phenotypic features and predictors of the clinical severity of keratoconjunctivitis sicca and salivary gland dysfunction in patients with Sjogren's syndrome: a longitudinal analysis of the Korean Initiative of primary Sjogren's Syndrome (KISS) cohort

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q3Scopus Q2
저널
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY48(3) · pp.198 · 2019
피인용
Web of Science 6Scopus 6
FWCI (Scopus)
0.22
JCR IF
JCR 2018 2.706
ISSN
0300-9742

저자

  1. 고정희제1저자Division of Rheumatology, Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Republic of Korea
  2. Lee, J.Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
  3. Chung, S. H.Department of Ophthalmology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
  4. Kwok, S. K.Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
  5. Park, S. H.교신저자Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

초록

Objective: The aim was to investigate prevalence and degree of ocular and oral involvement in patients with primary Sjogren's syndrome (PSS). Method: We analysed 134 participants from the Korean Initiative of PSS cohort who completed a 2 year follow-up oral and ocular sign test. The severity of keratoconjunctivitis sicca (KCS) was determined with the Schirmer I test value (STV) [abnormal (AB) <= 5 mm/5 min; normal (N) > 5 mm/5 min]. Salivary gland dysfunction (SGD) was determined by unstimulated whole salivary (UWS) flow rate [moderate to severe (MS) < 0.1 mL/min; mild (Mi) >= 0.1 mL/min]. Subgroups were divided into three groups according to STV and severity of SGD: AB-STV/MS-SGD, AB-STV/Mi-SGD, and N-STV/MS-SGD groups. We analysed the changes in STV and SGD during the follow-up period. Results: Among the 134 participants enrolled in this study, 105 (78%) were placed in the AB-STV/MS-SGD group, 16 (12%) in the AB-STV/Mi-SGD, and 13 (10%) in the N-STV/MS-SGD at the 2 year follow-up. The AB-STV/Mi-SGD group was younger than the other two groups, and had a lower Xerostomia Inventory score and lower level of beta(2)-microglobulin. Participants in the N-STV/MS-SGD group had less hyperimmunoglobulinaemia, rheumatoid factor (RF), and antinuclear antibodies (ANAs). Patients and those with positive RF or ANA >= 1:320 at baseline were more likely to have abnormal STV at the 2 year follow-up. Conclusions: Patients with PSS and positive RF or ANA >= 1:320 at baseline may benefit from regular ophthalmology examinations, even if they do not have KCS at baseline or dry eye symptoms.

키워드

RHEUMATOLOGY CLASSIFICATION CRITERIAQUALITY-OF-LIFEAMERICAN-COLLEGEDATA-DRIVENDRY EYEDISEASECONSENSUSPARTICIPANTSVALIDATIONVERSION

식별자

Scopus EID
2-s2.0-85057310925
WoS UID
000467940900004